Skip to search boxSkip to navigationSkip to main content

Colonizing and Virulence Factors in Enterotoxigenic Escherichia coli from Peru

  • ,
  • Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt
    ,
  • Universidad Peruana Cayetano Heredia
    ,
  • Universidad Nacional Federico Villarreal
    ,
  • School of Public Health, University of Texas
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 948-953 (6 pages)

Journal (Volume, Issue Number)

American Journal of Tropical Medicine and Hygiene (Volume 108, Issue 5)

Publication milestones

  • Published - 05/2023

Publication status

Published - 05/2023

ISSN

0002-9637

Publication IDs

  • Scopus: 85159546168
  • PubMed: 36972692

Abstract

Enterotoxigenic Escherichia coli (ETEC) ranks among the most relevant diarrheagenic pathogens. Efforts to design vaccines to fight ETEC have been focused on colonizing factors (CFs) and atypical virulence factors (AVF). An effective vaccine must account for differences in the regional prevalence of these CFs and AVFs to be truly effective in a given area. In the present study, the presence of 16 CFs and 9 AVFs, as well as the heat-stable (ST) variants (STh or STp), was established by polymerase chain reaction in 205 Peruvian ETEC isolates (120 from diarrhea cases and 85 from healthy controls). Ninety-nine (48.3%) isolates were heat-labile, 63 (30.7%) ST, and 43 (21.0%) presented both toxins. Of ST isolates, 59 (28.8%) possessed STh, 30 (14.6%) STp, five (2.4%) both STh and STp, and 12 (5.8%) were not amplified for any variant tested. The presence of CFs was associated with diarrhea (P, 0.0001). The presence of eatA as well as concomitant presence of CSI, CS3, and CS21 and of C5 and C6 was statistically related to diarrhea cases. The present results suggests that, if effective, a vaccine considering CS6, CS20, and CS21, together with EtpA, would provide protection against 64.4% of the isolates analyzed, whereas the addition of CS12 and EAST1 would lead to 83.9% coverage. Large studies are needed to establish both the ideal candidates to be considered to develop a vaccine effective in the area, and continuous surveillance is needed to detect displacement of circulating isolates that may compromise future vaccines.

Funding Details

J. R. was supported by the Universidad Cientifica del Sur and Fondo Nacional de Desarrollo Cientıfico, Tecnologico y de Innovacion Tecnologica (FONDECYT - Peru) within the “Proyecto de Mejoramiento y Ampliacion de los Servicios del Sistema Nacional de Ciencia, Tecnologıa e Innovacion Tecnologica ” [contract: 08-2019-FONDECYT-BM-INC-INV]. Financial support: J. R. was supported by the Universidad Cientifica del Sur and Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica (FONDECYT - Perú) within the “Proyecto de Mejoramiento y Ampliación de los Servicios del Sistema Nacional de Ciencia, Tecnología e Innovación Tecnológica” [contract: 08-2019-FONDECYT-BM-INC-INV].
FundersFunding numbers
Servicios del Sistema Nacional de Ciencia,Tecnología e Innovación Tecnológica
08-2019-FONDECYT-BM-INC-INV
Servicios del Sistema Nacional de Ciencia, Tecnologıa e Innovacion Tecnologica
-UCSUR: UCS-
FONDECYT
-

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Captures
7
Citations
1

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well